Enquiry/Quote
Fedratinib bulk supplier for pharma manufacturers

Fedratinib Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 100mg, 200mg

Reference Brands: Inrebic (USA/EU)

Category: Oncology Cancer Care

Fedratinib is an oral JAK2 inhibitor used for the treatment of adults with intermediate-2 or high-risk primary or secondary myelofibrosis. It helps reduce spleen size and improves disease-related symptoms by selectively targeting the JAK2 pathway involved in abnormal blood cell production. Fedratinib is available in Capsules and strengths such as 100mg, 200mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fedratinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Fedratinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Fedratinib is used for treating intermediate-2 or high-risk primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. It works as a selective JAK2 inhibitor that helps reduce spleen size and improve associated disease symptoms.

Fedratinib is made from the active ingredient fedratinib hydrochloride, a targeted small-molecule JAK2 inhibitor designed to block dysregulated signaling involved in myeloproliferative disorders.

The trade name is Inrebic.

Inrebic is manufactured and marketed by Celgene, which is now a part of Bristol-Myers Squibb (BMS).

The generic name is fedratinib hydrochloride.

The brand name is Inrebic.

Fedratinib is manufactured in the United States and Europe under Bristol-Myers Squibb’s regulated production facilities.

Yes, Fedratinib is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Fedratinib is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Capivasertib

Strength:
160 mg

Form: Tablets

Reference Brands: Truqap (USA)

View Details
Toremifene Citrate

Strength:
60 mg

Form: Tablets

Reference Brands: Fareston(USA)

View Details
Ivosidenib

Strength:
250 mg

Form: Tablets

Reference Brands: Tibsovo (USA/EU)

View Details
Thioguanine

Strength:
20 mg, 25 mg, 40 mg

Form: Tablets

Reference Brands: Tabloid (USA), Lanvis (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.